Skip to main content
. 2023 Mar 3;50(2):137–141. doi: 10.1097/WON.0000000000000951

TABLE 3. Rates of Incontinence and IAD During a Single Month From Each Observation Year.

Variable 2016 2018 P
Value (2016 vs 2018)
2019 P
Value (2016 vs 2019)
2018 + 2019 P
Value (2016 vs 2018 + 2019)
No. patients 56 69 62 131
Age, mean (SD), y 57.61 (15.4) 57.87 (16.2) .93a 57.84 (16.5) .94a .92a
Gender, n (%) .19b .96b .42b
Female 25 (44.6%) 39 (56.5%) 28 (45.2%) 67 (51.1%)
Male 31 (55.4%) 30 (43.5%) 34 (54.8%) 64 (48.9%)
Incontinence, n (%) .0130c .0050c .0040c
Fecal 10 (17.9%) 3 (4.3%) 5 (8.1%) 8 (6.1%)
Urinary 0 6 (8.7%) 5 (8.1%) 11 (8.4%)
Both 3 (5.4%) 6 (8.7%) 13 (21.0%) 19 (14.5%)
Not incontinent 43 (76.8%) 54 (78.3%) 39 (62.9%) 93 (71.0%)
IAD, n (%) .12c .08c .06c
Yes 9 (69.2%) 6 (40.0%) 9 (39.1%) 15 (39.5%)
No 4 (30.8%) 9 (60.0%) 14 (60.9%) 23 (60.5%)

Abbreviation: IAD, incontinence-associated dermatitis.

aAnalysis based on the t test.

bAnalysis using the χ2 test.

cAnalysis using Fisher's exact test.